Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_GLUCOSAMINE
Extra metadata
List of similar endpoints to
Glucosamine medication
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13338 | 9503 | 3835 |
| Unadjusted prevalence (%) | 5.13 | 6.47 | 3.39 |
| Mean age at first event (years) | 60.56 | 60.27 | 61.26 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.02 | 1.50 [1.29, 1.75] | 8.8e-8 | 1159 |
| 15 years | 0.01 | 1.56 [1.35, 1.81] | 2.6e-9 | 1159 |
| 5 years | 0.00 | 1.33 [1.12, 1.58] | 1.4e-3 | 221 |
| 1 year | 0.00 | 0.35 [0.19, 0.66] | 1.2e-3 | 10 |
Index endpoint: RX_GLUCOSAMINE – Glucosamine medication
GWS hits: 0
before Glucosamine medication
after Glucosamine medication
Loading survival analyses plot
Loading survival analyses table